Reply to "The allergic effector unit: From basic science to drug-targetable mast cell-eosinophil interactions in patients"

J Allergy Clin Immunol Pract. 2021 Oct;9(10):3846-3847. doi: 10.1016/j.jaip.2021.07.011.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eosinophils
  • Humans
  • Hypersensitivity*
  • Mast Cells
  • Pharmaceutical Preparations*

Substances

  • Pharmaceutical Preparations